Mabpro
Pre-clinicalMABPRO, a.s. develops personalized immunotherapy for aggressive, hypoxic tumors using CA IX targeting. Innovative treatment and diagnostics.
Founded
2006
Focus
AntibodiesBiologics
About
MABPRO, a.s. develops personalized immunotherapy for aggressive, hypoxic tumors using CA IX targeting. Innovative treatment and diagnostics.
Company Info
TypePrivate
Founded2006
LocationBratislava, Europe - Other
StagePre-clinical
Contact
SIMILAR COMPANIES
3D BioLabs
Pre-clinical · Sarajevo
Bilim Pharmaceuticals
Pre-clinical · Istanbul
3Z Pharmaceuticals
Pre-clinical · Reykjavik
ADAX
Pre-clinical · Ljubljana
Exolitus
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile